Jaundice Management—Jaundice Screening
Jaundice screening requires a technique that is noninvasive to minimize stress on the baby, yet it also needs to work instantly—and on all skin types—to ensure there is no delay in treatment and every infant receives the appropriate treatment.
The measurement of TSB and TcB levels for many, if not all, infants before discharge is becoming a common practice in the United States. In fact, it is recommended by the American Academy of Pediatrics as the best-documented method for predicting the likelihood of subsequent hyperbilirubinemia which can then reduce readmission rates.
Research more about Jaundice Screening techniques now.
Videos and Lectures
- Validating Assessment of Neonatal Jaundice with Transcutaneous Bilirubin Measurement
In response to current trends in maternity care, nurses are assuming a major role in providing quality care for new mothers and their babies post discharge through follow-up home care.
- Transcutaneous Bilirubin in the Pre-term Infants
To evaluate the accuracy of transcutaneous bilirubin (TCB) measurement compared to total serum bilirubin level (TSB) in the pre-term infants and 2) To establish cut-off values of TCB that indicated need for TSB.
- Transcutaneous Bilirubin Levels in the First 96 Hours - Maisels
We provide data on neonatal bilirubnemia , based on TCB levels determined in large, predominately white and breastfed, North American population.
- Evaluation of a New Transcutaneous Bilirubinometer_Maisels et al
The objective of this study was to evaluate the Minolta / Hill-Rom Air-Shields Transcutaneous Jaundice Meter model JM-103.
- Management of Hyperbilirubinemia in the Newborn Infant >35 Weeks of Gestation
Jaundice occurs in most newborn infants. Most jaundice is benign, but because of the potential toxicity of bilirubin, newborn infants must be monitored to identify those who might develop severe hyperbilirubinemia and, in rare cases, acute bilirubin encephalopathy or kernicterus.
- Neonatal Phototherapy - Today's Lights, Lamps and Devices
- Newborn Jaundice Screening Program-Calgary
Alberta Health Services (Calgary Region), in collaboration with Calgary Laboratory Services and the Division of Community Paediatrics, is the first place we know of to introduce a comprehensive newborn transcutaneous bilirubin (TcB) monitoring program which involves Acute Care sites as well as Public Health.
- A Newborn Jaundice Screening Program
According to the Canadian Paediatric Society, hyperbilirubinema occurs in about 60 percent of newborms of greater than 35 weeks’ gestation.
Title: Neonatal Jaundice
Editors: M. Jeffery Maisels and Jon F. Watchko
Publisher: OPA (Overseas Publishers Association)
Description: Jaundice is the most common abnormal physical sign found in the new-born infant. It occurs in around two-thirds of all normal babies in the first few days of life, and can lead to toxicity of the central nervous system. In the current era of cost containment, infants are leaving hospital much earlier and as bilirubin levels are rising at the time of discharge, physicians must now follow these infants as outpatients to make sure that severe jaundice does not occur. Neonatal Jaundice is the first complete source of current information for all physicians interested in the care of the new-born infant. When and how hyperbilirubinemia should be treated is a matter of ongoing controversy and this text presents a reasoned clinical approach to the management of the jaundiced new-born. The editors clearly describe the mechanisms, epidemiology and clinical diagnosis of the condition and review the current therapeutic options which include exchange transfusion, phototherapy and pharmacologic treatment.